Background: Mizoram is a small state in the northeastern part of India and recorded its first case of coronavirus disease 2019 (COVID-19) on March 24, 2020. The first registered death because of COVID-19 in the state was on October 28, 2020 at Zoram Medical College (ZMC), which is a dedicated COVID hospital in Mizoram. COVID-19 cases from different districts in the state were referred to ZMC according to severity of symptoms. NCDIR-ICMR e-Mortality Cell was first started as a project at ZMC in 2019. Since then, all hospital deaths are recorded using a structured questionnaire developed by NCDIR which has also strengthened the data for COVID-19 mortality statistics in the state. The objective of this study is to determine the association of in-hospital COVID-19 mortality in relation to age, sex, vaccine status, and underlying co-morbidities and highlight the utility of ICMR-NCDIR e-Mortality software in the hospital.
Methods: Data on COVID-19-associated deaths from October 2020 to October 2021 at ZMC were collected from the hospital e-Mortality software and Medical Records Department (MRD). This includes patients' demographic characteristics including age, sex, vaccination status, and underlying co-morbidities if any. Appropriate statistical analysis was performed to evaluate the correlation between variables.
Results: From October 2020 to October 2021, a total of 324 deaths related to COVID-19 was recorded at ZMC, Mizoram. The majority of the deaths were distributed in the age group 65 years and above and accounts for 49.1% in all age groups. Out of the total deaths, 64.2% (208) were males and 81.48% had an associated underlying co-morbidity besides COVID-19. The most common co-morbidities were hypertension, type 2 diabetes mellitus, cancer, and chronic obstructive pulmonary disease. More than half, 59.6%, had no vaccination history, and all the cases had no history of taking a booster vaccination dose. A statistically significant correlation between delay in time to admission and length of hospital stay (p = 0.017) was also seen.
Conclusions: COVID-19 is more severe in the older age group above 65 years of age and in males, particularly in the presence of underlying co-morbidities. Mortality was also higher in patients with no history of vaccination as compared with patients vaccinated. Also, delay in hospital admission increases the length of hospital stay and mortality.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114571 | PMC |
http://dx.doi.org/10.4103/jfmpc.jfmpc_1251_22 | DOI Listing |
PeerJ
January 2025
Departamento de genética, ecologia e evolução, Laboratório de biologia integrativa, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Background: The angiotensin-converting enzyme 2 (ACE2) and the transmembrane serine protease 2 (TMPRSS2) are central human molecules in the SARS-CoV-2 virus-host interaction. Evidence indicates that may influence expression. This study aims to determine whether ACE1, ACE2, and TMPRSS2 mRNA expression levels, along with the ACE1 Alu 287 bp polymorphism (rs4646994), contribute to the severity and mortality of COVID-19.
View Article and Find Full Text PDFFront Transplant
January 2025
Section of Transplant Surgery, Washington University School of Medicine, St. Louis, MO, United States.
Background: COVID-19 disease burden has been mitigated by vaccination; however, concerns persist regarding weakened immune responses in liver transplant (LT) recipients. This study investigates COVID-19 outcomes in LT recipients based on vaccination status.
Methods: This single-center retrospective study identified LT recipients with PCR-confirmed COVID-19 infection from 03/01/2020 to 07/31/2023.
Glob Epidemiol
June 2025
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Brazil.
Unlabelled: COVID-19 is no longer a global health emergency, but it remains challenging to predict its prognosis.
Objective: To develop and validate an instrument to predict COVID-19 progression for critically ill hospitalized patients in a Brazilian population.
Methodology: Observational study with retrospective follow-up.
Arch Public Health
January 2025
Department of Health Administration, College of Health Science, Dankook University, 119 Dandaero, Dongnam-gu, Cheonan city, Chungcheongnam-do, 31116, Republic of Korea.
Background: Comorbidities or complications significantly influence coronavirus disease-2019 (COVID-19) severity and mortality risk. Therefore, this study aimed to compare treatment outcomes of COVID-19 inpatients by underlying diseases or complications.
Method: Data on COVID-19 patients from the National Health Insurance Service customized research database were analyzed while focusing on eight underlying diseases and complications: diabetes, hypertension, heart disease, kidney disease, liver disease, dementia, depression, and respiratory disease.
BMC Infect Dis
January 2025
Department of Virology, School of Public Health, National Measles Laboratory (NML), Tehran University of Medical Sciences, Tehran, Iran.
Background: Measles, an ongoing public health concern, demands continuous molecular surveillance and virus characterization for elimination. Despite Iran achieving measles elimination status in 2019 through robust molecular testing and vaccination, the COVID-19 pandemic disrupted global vaccination efforts, leading to increased measles-related morbidity and mortality. This study aims to overview measles virus serological and molecular traits in Iran from 1st January 2021 to 30th April 2023.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!